Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Identification of Brain Metastasis Initiating Cells and Regulators of Brain Metastasis from Lung Cancer

Project Overview

A recent study by the Massague group has identified genes that mediated breast cancer metastasis to the brain by using genomic expression analysis to compare in vivo-selected brain metastasis cell lines to the corresponding parental lines. Knockdown of these genes reduced the migration and invasiveness of BM-derived cells in vitro and in vivo. Another group using in vivo selection identified a set of Wnt3a-regulated genes to be predictive of lung metastasis to the brain. While these studies identify genes important in the invasiveness and metastasis of tumour cells to the brain, any involvement in the CSC properties of self-renewal or differentiation has yet to be shown. Furthermore, these gene signatures may be biased by in vivo selection which identifies genes useful in growing in mouse brains; they also lack a primary brain tumour comparison. As such, the true predictive value and involvement in brain metastasis of these genes is uncertain. We will address these limitations by identifying BM genes through genomic comparisons of primary brain and lung tumours to lung-derived BMs, and applying our in vitro and in vivo BTIC models to characterize the importance of these genes in CSC properties and invasion. Prior work conducted in our lab has demonstrated that BMs have a similar sphere-formation capacity as primary brain tumour samples when exposed to neural stem cell (NSC) conditions, where sphere-formation correlates with self-renewal. Known BTIC markers are also expressed in BMs, in percentages similar to those in primary brain tumours however, they were not useful in identifying functionally distinct populations. BMs may also possess a mixed-lineage differentiation capacity. These results are consistent with the presence of a CSC population. In collaboration with Dr. Marco Marra (BC Cancer Agency) we have identified a list of 30 candidate genes as being significantly overexpressed in an enriched stem cell population for BM, primary brain and lung tumours through transcriptome analysis.

Principal Investigator

Mohini Singh , McMaster University

Partners and Donors

CIBC

Project Complete

Identification of Brain Metastasis Initiating Cells and Regulators of Brain Metastasis from Lung Cancer

  • Grant Type

    Capacity building grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    Brain Canada - CIBC Brain Cancer Research Training Awards

  • Province

    Ontario

  • Start Date

    2013

  • Total Grant Amount

    $105,000

  • Health Canada Contribution

    $52,500

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now